Effectiveness and safety of tranexamic acid in spinal deformity surgery

Ho Yong Choi, Seong Jae Hyun, Ki Jeong Kim, Tae An Chang, Hyun Jib Kim

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Objective: Spinal deformity surgery has the potential risk of massive blood loss. To reduce surgical bleeding, the use of tranexamic acid (TXA) became popular in spinal surgery, recently. The purpose of this study was to determine the effectiveness of intraoperative TXA use to reduce surgical bleeding and transfusion requirements in spinal deformity surgery. Methods: A total of 132 consecutive patients undergoing multi-level posterior spinal segmental instrumented fusion (≥5 levels) were analyzed retrospectively. Primary outcome measures included intraoperative estimated blood loss (EBL), transfusion amount and rate of transfusion. Secondary outcome measures included postoperative transfusion amount, rate of transfusion, and complications associated with TXA or allogeneic blood transfusions. Results: The number of patients was 89 in TXA group and 43 in non-TXA group. There were no significant differences in demographic or surgical traits between the groups except hypertension. The EBL was significantly lower in TXA group than non-TXA group (841 vs. 1336 mL, p=0.002). TXA group also showed less intra-operative and postoperative transfusion requirements (544 vs. 812 mL, p=0.012; 193 vs. 359 mL, p=0.034). Based on multiple regression analysis, TXA use could reduce surgical bleeding by 371 mL (37 % of mean EBL). Complication rate was not different between the groups. Conclusion: TXA use can effectively reduce the amount of intra-operative bleeding and transfusion requirements in spinal deformity surgery. Future randomized controlled study could confirm the routine use of TXA in major spinal surgery.

Original languageEnglish
Pages (from-to)75-81
Number of pages7
JournalJournal of Korean Neurosurgical Society
Volume60
Issue number1
DOIs
StatePublished - 1 Jan 2017

Fingerprint

Tranexamic Acid
Safety
Hemorrhage
Blood Transfusion
Outcome Assessment (Health Care)
Acids
Regression Analysis
Demography
Hypertension

Keywords

  • Antifibrinolytics
  • Spinal surgery
  • Surgical blood loss
  • Tranexamic acid

Cite this

@article{7a0275f61dd544f49b96340d7c73a206,
title = "Effectiveness and safety of tranexamic acid in spinal deformity surgery",
abstract = "Objective: Spinal deformity surgery has the potential risk of massive blood loss. To reduce surgical bleeding, the use of tranexamic acid (TXA) became popular in spinal surgery, recently. The purpose of this study was to determine the effectiveness of intraoperative TXA use to reduce surgical bleeding and transfusion requirements in spinal deformity surgery. Methods: A total of 132 consecutive patients undergoing multi-level posterior spinal segmental instrumented fusion (≥5 levels) were analyzed retrospectively. Primary outcome measures included intraoperative estimated blood loss (EBL), transfusion amount and rate of transfusion. Secondary outcome measures included postoperative transfusion amount, rate of transfusion, and complications associated with TXA or allogeneic blood transfusions. Results: The number of patients was 89 in TXA group and 43 in non-TXA group. There were no significant differences in demographic or surgical traits between the groups except hypertension. The EBL was significantly lower in TXA group than non-TXA group (841 vs. 1336 mL, p=0.002). TXA group also showed less intra-operative and postoperative transfusion requirements (544 vs. 812 mL, p=0.012; 193 vs. 359 mL, p=0.034). Based on multiple regression analysis, TXA use could reduce surgical bleeding by 371 mL (37 {\%} of mean EBL). Complication rate was not different between the groups. Conclusion: TXA use can effectively reduce the amount of intra-operative bleeding and transfusion requirements in spinal deformity surgery. Future randomized controlled study could confirm the routine use of TXA in major spinal surgery.",
keywords = "Antifibrinolytics, Spinal surgery, Surgical blood loss, Tranexamic acid",
author = "Choi, {Ho Yong} and Hyun, {Seong Jae} and Kim, {Ki Jeong} and Chang, {Tae An} and Kim, {Hyun Jib}",
year = "2017",
month = "1",
day = "1",
doi = "10.3340/jkns.2016.0505.004",
language = "English",
volume = "60",
pages = "75--81",
journal = "Journal of Korean Neurosurgical Society",
issn = "2005-3711",
publisher = "Korean Neurosurgical Society",
number = "1",

}

Effectiveness and safety of tranexamic acid in spinal deformity surgery. / Choi, Ho Yong; Hyun, Seong Jae; Kim, Ki Jeong; Chang, Tae An; Kim, Hyun Jib.

In: Journal of Korean Neurosurgical Society, Vol. 60, No. 1, 01.01.2017, p. 75-81.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Effectiveness and safety of tranexamic acid in spinal deformity surgery

AU - Choi, Ho Yong

AU - Hyun, Seong Jae

AU - Kim, Ki Jeong

AU - Chang, Tae An

AU - Kim, Hyun Jib

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective: Spinal deformity surgery has the potential risk of massive blood loss. To reduce surgical bleeding, the use of tranexamic acid (TXA) became popular in spinal surgery, recently. The purpose of this study was to determine the effectiveness of intraoperative TXA use to reduce surgical bleeding and transfusion requirements in spinal deformity surgery. Methods: A total of 132 consecutive patients undergoing multi-level posterior spinal segmental instrumented fusion (≥5 levels) were analyzed retrospectively. Primary outcome measures included intraoperative estimated blood loss (EBL), transfusion amount and rate of transfusion. Secondary outcome measures included postoperative transfusion amount, rate of transfusion, and complications associated with TXA or allogeneic blood transfusions. Results: The number of patients was 89 in TXA group and 43 in non-TXA group. There were no significant differences in demographic or surgical traits between the groups except hypertension. The EBL was significantly lower in TXA group than non-TXA group (841 vs. 1336 mL, p=0.002). TXA group also showed less intra-operative and postoperative transfusion requirements (544 vs. 812 mL, p=0.012; 193 vs. 359 mL, p=0.034). Based on multiple regression analysis, TXA use could reduce surgical bleeding by 371 mL (37 % of mean EBL). Complication rate was not different between the groups. Conclusion: TXA use can effectively reduce the amount of intra-operative bleeding and transfusion requirements in spinal deformity surgery. Future randomized controlled study could confirm the routine use of TXA in major spinal surgery.

AB - Objective: Spinal deformity surgery has the potential risk of massive blood loss. To reduce surgical bleeding, the use of tranexamic acid (TXA) became popular in spinal surgery, recently. The purpose of this study was to determine the effectiveness of intraoperative TXA use to reduce surgical bleeding and transfusion requirements in spinal deformity surgery. Methods: A total of 132 consecutive patients undergoing multi-level posterior spinal segmental instrumented fusion (≥5 levels) were analyzed retrospectively. Primary outcome measures included intraoperative estimated blood loss (EBL), transfusion amount and rate of transfusion. Secondary outcome measures included postoperative transfusion amount, rate of transfusion, and complications associated with TXA or allogeneic blood transfusions. Results: The number of patients was 89 in TXA group and 43 in non-TXA group. There were no significant differences in demographic or surgical traits between the groups except hypertension. The EBL was significantly lower in TXA group than non-TXA group (841 vs. 1336 mL, p=0.002). TXA group also showed less intra-operative and postoperative transfusion requirements (544 vs. 812 mL, p=0.012; 193 vs. 359 mL, p=0.034). Based on multiple regression analysis, TXA use could reduce surgical bleeding by 371 mL (37 % of mean EBL). Complication rate was not different between the groups. Conclusion: TXA use can effectively reduce the amount of intra-operative bleeding and transfusion requirements in spinal deformity surgery. Future randomized controlled study could confirm the routine use of TXA in major spinal surgery.

KW - Antifibrinolytics

KW - Spinal surgery

KW - Surgical blood loss

KW - Tranexamic acid

UR - http://www.scopus.com/inward/record.url?scp=85010443392&partnerID=8YFLogxK

U2 - 10.3340/jkns.2016.0505.004

DO - 10.3340/jkns.2016.0505.004

M3 - Article

AN - SCOPUS:85010443392

VL - 60

SP - 75

EP - 81

JO - Journal of Korean Neurosurgical Society

JF - Journal of Korean Neurosurgical Society

SN - 2005-3711

IS - 1

ER -